UiPath CEO sells 45,000 shares at $15 under 10b5-1 plan
UiPath (PATH): Insider transaction disclosed.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UiPath (PATH): Insider transaction disclosed. A reporting person who serves as CEO and Chairman, and is also a director and 10% owner, sold 45,000 shares of Class A common stock on 11/05/2025. The reported transaction price was $15.0748 per share; the filing notes executions occurred between $15.00 and $15.15 under a Rule 10b5-1 trading plan. Following the sale, the reporting person directly owned 29,288,585 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 45,000 | $15.0748 | $678K |
Footnotes (2)
- F1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- F2. The range of prices for the transactions reported was from $15.0000 to $15.1500. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did PATH report?
Was the PATH sale under a 10b5-1 plan?
What is the insider’s relationship to UiPath (PATH)?
What was the form type for this disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.